SIRT1: Harnessing multiple pathways to hinder NAFLD
Non-alcoholic fatty liver disease (NAFLD) encompasses hepatic steatosis, non-alcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and hepatocellular carcinoma. It is the primary cause of chronic liver disorders, with a high prevalence but no approved treatment. Therefore, it is indispensable to fi...
Saved in:
Main Authors: | Cheng Tian (Author), Rongrong Huang (Author), Ming Xiang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Salvia-Nelumbinis naturalis improves lipid metabolism of NAFLD by regulating the SIRT1/AMPK signaling pathway
by: Yang Liu, et al.
Published: (2022) -
Activation of the AMPK-SIRT1 pathway contributes to protective effects of Salvianolic acid A against lipotoxicity in hepatocytes and NAFLD in mice
by: Songtao Li, et al.
Published: (2020) -
17β-Estradiol (E<sub>2</sub>) Upregulates the ERα/SIRT1/PGC-1α Signaling Pathway and Protects Mitochondrial Function to Prevent Bilateral Oophorectomy (OVX)-Induced Nonalcoholic Fatty Liver Disease (NAFLD)
by: Ying Tian, et al.
Published: (2023) -
NAFLD and Diabetes: Two Sides of the Same Coin? Rationale for Gene-Based Personalized NAFLD Treatment
by: Ming-Feng Xia, et al.
Published: (2019) -
Apigenin Prevents Acetaminophen-Induced Liver Injury by Activating the SIRT1 Pathway
by: Licong Zhao, et al.
Published: (2020)